Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Healthcare | 2.87% |
| 3 | Financials | 2.57% |
| 4 | Consumer Discretionary | 2.23% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8476
CVRx
CVRX
$82.1M
| $429K | ﹤0.01% |
+23,365
| New | +$288K |
|
|
MYOV
8477
CALL
DELISTED
Myovant Sciences Ltd.
MYOV
| $429K | ﹤0.01% |
15,900
-118,100
| -88% | -$3.11M |
|
8478
CALL
4D Molecular Therapeutics
FDMT
$637M
| $429K | ﹤0.01% |
19,300
-70,100
| -78% | -$1.08M |
|
8479
iRadimed
IRMD
$1.11B
| $428K | ﹤0.01% |
+15,145
| New | +$433K |
|
|
RNAM
8480
CALL
DELISTED
Avidity Biosciences
RNAM
| $428K | ﹤0.01% |
19,300
-37,200
| -66% | -$555K |
|
|
RDFN
8481
DELISTED
Redfin
RDFN
| $428K | ﹤0.01% |
100,911
+4,938
| +5% | +$23.2K |
|
8482
PUT
Core Laboratories
CLB
$571M
| $428K | ﹤0.01% |
21,100
+6,100
| +41% | +$118K |
|
8483
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$334M
| $428K | ﹤0.01% |
10,893
-39,489
| -78% | -$1.54M |
|
8484
FundX Aggressive ETF
XNAV
$31.9M
| $427K | ﹤0.01% |
+8,580
| New | +$434K |
|
8485
CALL
Vanguard Total International Bond ETF
BNDX
$82.7B
| $427K | ﹤0.01% |
9,000
-15,600
| -63% | -$751K |
|
8486
CALL
Magnolia Oil & Gas
MGY
$6.22B
| $427K | ﹤0.01% |
18,200
+1,800
| +11% | +$43.9K |
|
8487
PUT
Oceaneering
OII
$5.2B
| $427K | ﹤0.01% |
24,400
+13,300
| +120% | +$177K |
|
8488
CALL
Cogent Biosciences
COGT
$6.58B
| $427K | ﹤0.01% |
36,900
-11,100
| -23% | -$138K |
|
|
GMS
8489
DELISTED
GMS Inc
GMS
| $426K | ﹤0.01% |
8,558
-23,692
| -73% | -$1.14M |
|
8490
PUT
Cedar Fair
FUN
$1.68B
| $426K | ﹤0.01% |
10,300
-18,700
| -64% | -$751K |
|
8491
Amplify International Enhanced Dividend Income ETF
IDVO
$1.38B
| $426K | ﹤0.01% |
16,375
-15,482
| -49% | -$392K |
|
|
NVTA
8492
PUT
DELISTED
Invitae Corporation
NVTA
| $426K | ﹤0.01% |
228,800
-217,100
| -49% | -$530K |
|
|
PPTY
8493
US Diversified Real Estate ETF
PPTY
$25.5M
| $425K | ﹤0.01% |
15,168
+2,996
| +25% | +$84.9K |
|
8494
iShares US Healthcare ETF
IYH
$3.75B
| $425K | ﹤0.01% |
7,490
-46,745
| -86% | -$2.58M |
|
|
LOGC
8495
PUT
DELISTED
ContextLogic
LOGC
| $425K | ﹤0.01% |
29,043
+4,746
| +20% | +$97.6K |
|
8496
CALL
Euronet Worldwide
EEFT
$2.74B
| $425K | ﹤0.01% |
4,500
-4,700
| -51% | -$407K |
|
|
RIDE
8497
PUT
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $425K | ﹤0.01% |
24,833
+6,820
| +38% | +$158K |
|
8498
CALL
First Bancorp
FBNC
$2.74B
| $424K | ﹤0.01% |
+9,900
| New | +$434K |
|
|
UROY
8499
PUT
Uranium Royalty Corp
UROY
$1.57B
| $424K | ﹤0.01% |
178,800
+37,100
| +26% | +$90.3K |
|
8500
CALL
Columbia Financial
CLBK
$1.23B
| $424K | ﹤0.01% |
19,600
+9,300
| +90% | +$200K |
|
Similar funds
Citadel Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Citadel Advisors held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in Denbury Inc. worth $107M.
- Citadel Advisors's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Citadel Advisors added most to Tesla in Q4 2022, an estimated $913M increase.
- Citadel Advisors's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Citadel Advisors fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Citadel Advisors's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Citadel Advisors opened 3,614 new positions and closed 1,312 in Q4 2022.
- Citadel Advisors's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.